Resonac Holdings Past Earnings Performance
Past criteria checks 1/6
Resonac Holdings's earnings have been declining at an average annual rate of -13.7%, while the Chemicals industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 9.3% per year. Resonac Holdings's return on equity is 6.1%, and it has net margins of 2.9%.
Key information
-13.7%
Earnings growth rate
-15.6%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 9.3% |
| Return on equity | 6.1% |
| Net Margin | 2.9% |
| Next Earnings Update | 12 Nov 2024 |
Recent past performance updates
Recent updates
The Resonac Holdings Corporation (TSE:4004) Interim Results Are Out And Analysts Have Published New Forecasts
Aug 12
Resonac Holdings (TSE:4004) Has No Shortage Of Debt
Jul 27With Resonac Holdings Corporation (TSE:4004) It Looks Like You'll Get What You Pay For
Jul 05Is Resonac Holdings (TSE:4004) Using Too Much Debt?
Mar 22Are Investors Undervaluing Resonac Holdings Corporation (TSE:4004) By 38%?
Mar 01Revenue & Expenses Breakdown
How Resonac Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,341,290 | 39,307 | 250,386 | 0 |
| 31 Mar 24 | 1,311,324 | 20,371 | 221,830 | 0 |
| 31 Dec 23 | 1,288,869 | -18,955 | 221,801 | 0 |
| 30 Sep 23 | 1,300,776 | -11,025 | 194,459 | 26,079 |
| 30 Jun 23 | 1,352,714 | -20,751 | 196,872 | 26,079 |
| 31 Mar 23 | 1,383,548 | 10,096 | 194,069 | 26,079 |
| 31 Dec 22 | 1,392,621 | 30,793 | 191,575 | 26,079 |
| 30 Sep 22 | 1,402,091 | 33,687 | 187,808 | 28,619 |
| 30 Jun 22 | 1,382,310 | 33,045 | 187,783 | 28,619 |
| 31 Mar 22 | 1,387,948 | -8,851 | 192,037 | 28,619 |
| 31 Dec 21 | 1,419,635 | -12,094 | 194,561 | 28,619 |
| 30 Sep 21 | 1,389,419 | -28,980 | 234,443 | 18,154 |
| 30 Jun 21 | 1,340,437 | -35,141 | 229,868 | 18,154 |
| 31 Mar 21 | 1,141,645 | -73,812 | 194,951 | 18,154 |
| 31 Dec 20 | 973,700 | -76,304 | 160,617 | 18,154 |
| 30 Sep 20 | 846,856 | -65,529 | 143,607 | 0 |
| 30 Jun 20 | 757,581 | -47,300 | 115,004 | 0 |
| 31 Mar 20 | 843,461 | 42,713 | 114,681 | 0 |
| 31 Dec 19 | 906,454 | 73,088 | 114,499 | 0 |
| 30 Sep 19 | 962,773 | 93,194 | 110,866 | 0 |
| 30 Jun 19 | 1,011,785 | 119,184 | 109,446 | 0 |
| 31 Mar 19 | 1,012,169 | 119,826 | 108,952 | 0 |
| 31 Dec 18 | 992,136 | 111,503 | 107,130 | 0 |
| 30 Sep 18 | 941,512 | 109,305 | 108,155 | 0 |
| 30 Jun 18 | 864,039 | 83,765 | 105,392 | 0 |
| 31 Mar 18 | 811,888 | 43,668 | 101,445 | 0 |
| 31 Dec 17 | 780,387 | 33,470 | 99,791 | 0 |
| 30 Sep 17 | 750,562 | 24,204 | 94,903 | 0 |
| 30 Jun 17 | 724,688 | 17,811 | 91,288 | 0 |
| 31 Mar 17 | 698,356 | 25,946 | 87,068 | 0 |
| 31 Dec 16 | 671,159 | 12,305 | 84,111 | 0 |
| 30 Sep 16 | 670,266 | 8,912 | 81,920 | 0 |
| 30 Jun 16 | 700,160 | 1,697 | 84,408 | 0 |
| 31 Mar 16 | 739,872 | 9,385 | 86,358 | 0 |
| 31 Dec 15 | 775,732 | 921 | 88,299 | 0 |
| 30 Sep 15 | 819,041 | 4,840 | 90,524 | 0 |
| 30 Jun 15 | 855,394 | 8,457 | 89,887 | 0 |
| 31 Mar 15 | 855,826 | -5,074 | 88,990 | 0 |
| 31 Dec 14 | 872,785 | 2,929 | 88,081 | 0 |
| 30 Sep 14 | 873,887 | 3,951 | 86,334 | 0 |
| 30 Jun 14 | 858,021 | 2,934 | 85,190 | 0 |
| 31 Mar 14 | 864,139 | 5,437 | 84,608 | 0 |
| 31 Dec 13 | 847,803 | 9,065 | 83,101 | 0 |
| 30 Sep 13 | 810,267 | 4,881 | 82,820 | 0 |
Quality Earnings: 4004 has a large one-off gain of ¥9.9B impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: 4004 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4004's earnings have declined by 13.7% per year over the past 5 years.
Accelerating Growth: 4004 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 4004 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (10.9%).
Return on Equity
High ROE: 4004's Return on Equity (6.1%) is considered low.